Session Description: Economic modeling of Type 2 Diabetes Mellitus (T2DM) occupies a unique place on the cutting edge of health economics. It has a relatively long history (dating back to the seminal NIH model in 1997) and the sophisticated nature of the models themselves has, in part, led to...

Objective: The primary objective of this study was to estimate the cost effectiveness of treating diabetic foot ulcers with becaplermin (Regranex(R)) plus good wound care (GWC) compared with GWC alone in a variety of European healthcare settings. A secondary objective was to analyse the effect...

Background: Value-based pricing (VBP), whereby prices are set according to the perceived benefits offered to the consumer at a time when costs and benefits are characterized by considerable uncertainty and are then reviewed ex post, is a much discussed topic in pharmaceutical reimbursement. It...

The wave of bank failures during the late 1980s was comparable in magnitude to the one witnessed during the Great Depression. The absence of any corresponding economic downturn during the recent crisis, however, initially created a certain mystery as to its causes. By 1990, a near-consensus had...